ArticleTherapeutic advances in gastroenterology2019

Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms.

Blanca Serrano-Falcón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.